Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...

as well as pausing pre-clinical drug candidate programs; Scaling the U.S. commercial field team and supporting roles across the company;Streamlining other spending to support the ongoing clinical ...

Initially launched as part of the Company’s contract research services (CRS), CN Bio’s human DILI assay has been further refined into an all-in-one kit to optimize preclinical drug development ...

LONDON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, announced today that it will ...

Initially launched as part of the Company’s contract research services (CRS) 3, CN Bio’s human DILI assay has been further refined into an all-in-one kit to optimize preclinical drug development ...

These models better simulate tumor molecular mechanisms and treatments, with the organoid-based patient-derived xenograft model (O-PDX) showing great promise in drug screening and ... that summarizes ...

Collaborative research initiatives and strategic partnerships among academia, industry, and healthcare providers are accelerating the development and adoption of preclinical imaging platforms. As ...

Officials say it is clearly underdiagnosed and may be due to a problem drug treatment centers have ... 7.2 million federal grant to implement a new model that makes integrated care easier and ...

Despite its strong niche in services and preclinical drug discovery, the company’s prospects in its DAS segment are somewhat limited, as it does not have a strong presence in stickier areas like ...

SaveHealth explores the potential savings that can be achieved by intelligently leveraging cash prices and discount savings cards, providing insights based on real-world drug pricing data.